Guyana approves Made-in-India vaccine Covaxin, to allow vaccinated travellers to enter country
In a statement, the Guyanese health ministry listed out the vaccines approved for the travellers who wish to visit the country.
FollowGuyana has granted permission for people immunized with the Made-in-India vaccine Covaxin to enter the nation. In a statement, the Guyanese health ministry listed out the vaccines approved for the travellers who wish to visit the country. Taking to the micro-blogging site, the Indian High Commission in Guyana said that the country had recognized India's indigenous vaccine COVAXIN. It called the approval a significant step forward in the post-COVID partnership. They also tweeted a photo of Prime Minister Narendra Modi with Guyanese President Irfaan Ali during the current United Nations Climate Change Conference in Glasgow, Scotland.
Also Read | WHO seeks ‘additional clarifications’ from Bharat Biotech to approve Covaxin
Earlier Monday, the Australian government recognized Covaxinor to determine a traveller's vaccination status in the country. The World Health Organization has requested more details from Bharat Biotech, the company that makes Covaxin, and a decision on emergency use authorization is likely soon.
Guyana, which has a population of slightly more than 700,000 people and is the only country in South America where English is the official language, formerly recognized the following Covid-19 vaccines: Oxford-AstraZeneca, Sputnik V, Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, and Jansen are among the companies involved.
Also Read |Â Australia adds Indian vaccine Covaxin to its list of approved COVID vaccines
Covaxin has just been added to the list of authorized vaccinations in countries such as Australia and Oman. Mauritius, the Philippines, Nepal, Mexico, Iran, Sri Lanka, Greece, Estonia, and Zimbabwe are among the countries that have authorized the Bharat Biotech International Limited-developed vaccine. The World Health Organization will host a review conference on November 3 to explore giving Covaxin emergency use listing. Members of the global health organization's technical advisory committee (TAG) convened on October 26 to examine the matter but agreed that additional clarity from Bharat Biotech was necessary.
Â
